Proceedings: Inhibition of thrombotic side effects of II, VII, IX and X concentrates.
D001779:Blood Coagulation Factors / Q000009:adverse effects*; D004789:Enzyme Activation / Q000187:drug effects; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D001779:Blood Coagulation Factors; D006493:Heparin